京都大学 / 新制・論文博士 / 博士(医学) / 乙第13603号 / 論医博第2313号 / 京都大学大学院医学研究科医学専攻 / (主査)教授 森田 智視, 教授 佐藤 俊哉, 教授 永井 純正 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM
Identifer | oai:union.ndltd.org:kyoto-u.ac.jp/oai:repository.kulib.kyoto-u.ac.jp:2433/288434 |
Date | 25 March 2024 |
Creators | Shimazu, Yutaka |
Contributors | シマヅ, ユタカ |
Publisher | Kyoto University, 京都大学 |
Source Sets | Kyoto University |
Language | English |
Detected Language | English |
Type | doctoral thesis, Thesis or Dissertation |
Rights | 1.Shimazu Y, Kanda J, Kaneko H, et al. Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. Therapeutic Advances in Hematology. 2022;13. doi:10.1177/20406207221142487 2.Shimazu, Y., Kanda, J., Kosugi, S. et al. Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin. Scientific Reports 13, 5159 (2023). https://doi.org/10.1038/s41598-023-32426-6 |
Relation | https://doi.org/10.1177/20406207221142487, https://doi.org/10.1038/s41598-023-32426-6 |
Page generated in 0.0021 seconds